Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations

Area of Science:

• Genetics
• Epidemiology
• Biostatistics

Background:

• Traditional Relative Risk (RR) calculations can face challenges with appropriate control group selection.
• Accurate disease risk assessment in the presence of specific genetic markers is crucial for understanding disease etiology.

Purpose of the Study:

• To propose and validate a novel Haplotype Relative Risk (HRR) statistic as an alternative to the conventional RR.
• To address limitations in control sample selection inherent in traditional RR methods.

Main Methods:

• Developed the Haplotype Relative Risk (HRR) statistic using parental haplotypes not present in affected children as the control sample.
• Mathematically demonstrated the equivalence of HRR and RR expectations in family studies with unambiguous haplotype transmission.
• Applied the HRR statistic to study genetic associations with insulin-dependent diabetes mellitus (IDDM) using HLA antigens.

Main Results:

• The HRR statistic provides a reliable alternative to the RR by utilizing an appropriate control sample derived from the same population.
• HRR offers an advantage in family-based studies as the control sample is intrinsically included.
• Estimates of disease risk for HLA antigens associated with IDDM were obtained using the HRR statistic.

Conclusions:

• The Haplotype Relative Risk (HRR) statistic is a valid and advantageous alternative to the Relative Risk (RR) for genetic association studies.
• HRR simplifies study design and enhances data reliability by integrating control samples within family data.
• This method facilitates more accurate risk assessment for diseases with known genetic associations, such as IDDM.